Mobile Menu - OpenMobile Menu - Closed

Congressman Chris Collins

Representing the 27th District of New York

Vision banner

Collins proud to see Kids First Research Act signed into law

May 14, 2014
In The News

U.S. Rep. Chris Collins recently applauded the bipartisan effort that led President Obama to sign the Gabriella Miller Kids First Research Act into law.

Collins was House co-sponsor of the legislation, which will eliminate federal funding for presidential campaigns and party conventions and reallocate the funding to expand pediatric research at the National Institutes of Health (NIH).

“The Gabriella Miller Kids First Research Act is a bipartisan achievement transcending party politics to place a priority on the health and wellbeing of our nation’s children,” the Clarence Republican said. “As a longtime supporter of this legislation I am proud to see it signed into law and am grateful for the positive impact it will have on children in New York’s 27th Congressional District and across the country.”

Federal taxpayer dollars that are spent on political activities, will help the NIH cure and prevent juvenile (type 1) diabetes, childhood cancers, autism, Down Syndrome, and other illnesses and conditions, Collins said.

Collins pushed for passage of the legislation last year alongside several local families affected by juvenile diabetes. Collins also encouraged the general public to become “citizen co-sponsors” of the bill.

This legislation has the support of the Juvenile Diabetes Research Foundation (JDRF), Autism Speaks, the Children’s Hospital Association, the Coalition of Pediatric Medical Research, the National Down Syndrome Society and the Leukemia and Lymphoma Society, among others.

The legislation is named for Gabriella Miller, a girl from Virginia who fought to raise awareness as to the need for pediatric cancer research and who died of brain cancer last year at the age of 10.

The House passed the Gabriella Miller Kids First Research Act on Dec. 11, 2013, in a 294-103 vote. The Senate passed it this past March 11 with unanimous consent.

Issues: